Eclaran (Gel) Instructions for Use
ATC Code
D10AE01 (Benzoyl peroxide)
Active Substance
Benzoyl peroxide (USAN adopted for use in the USA)
Clinical-Pharmacological Group
Acne treatment drug
Pharmacotherapeutic Group
Antiseptic
Pharmacological Action
Antimicrobial agent for external use. It has an antimicrobial effect. It is active against gram-positive bacteria: Propionibacterium, Staphylococcus epidermidis.
It has a keratolytic effect, improves tissue oxygenation, and the process of granulation of lower limb ulcers. It reduces the formation of fat by the sebaceous glands of the skin.
Pharmacokinetics
When applied externally, it is practically not absorbed. A small amount is absorbed through the skin. It is metabolized to form benzoic acid. It is excreted by the kidneys in the form of benzoate.
Indications
- Acne vulgaris, including the conglobate form as a component of a comprehensive therapeutic regimen.
- Lower leg ulcers of diverse etiology, encompassing trophic ulcers resulting from venous insufficiency or other underlying pathologies.
ICD codes
| ICD-10 code | Indication |
| L70 | Acne |
| L98.4 | Chronic skin ulcer, not elsewhere classified |
| ICD-11 code | Indication |
| EA40 | Tropical phagedenic ulcer |
| ED80.Z | Acne, unspecified |
| EF60 | Ischemic ulceration of the skin |
| EM0Z | Unspecified skin disorder |
| ME60.2 | Ulcerative skin lesion of unspecified nature |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply the gel topically to cleansed and dried affected skin areas. For acne vulgaris, initiate therapy with the 5% gel formulation once daily for a duration of two to three weeks.
Subsequently, transition to the 10% gel strength, continuing application until complete resolution of cutaneous lesions is achieved. For the management of lower leg ulcers, utilize the 10% gel under an occlusive dressing, applied twice daily for a period of two to three weeks.
Adverse Reactions
Common adverse effects are predominantly localized to the site of application. These include skin erythema, a pronounced dryness and peeling of the epidermis, and a local irritant effect characterized by a burning or stinging sensation.
Less frequently, allergic contact dermatitis may manifest. Systemic reactions are exceedingly rare due to minimal percutaneous absorption of the active pharmaceutical ingredient.
Drug Interactions
Concomitant use with other topical acne medications, especially those containing tretinoin or its derivatives, may result in a significant increase in skin irritation and erythema. Exercise caution when applying other topical preparations to the same anatomical site.
Avoid concurrent use with abrasive or highly desiccating cleansers, astringents, and products with high concentrations of alcohol, as these may exacerbate the drying and irritant effects of the therapy.
Contraindications
- Hypersensitivity to benzoyl peroxide, any of the excipients in the formulation, or other peroxide compounds, which may present as contact dermatitis or more severe allergic responses.
- Application to skin with significant abrasions, eczematous eruptions, or sunburn, as the irritant properties of the drug may exacerbate these conditions and impede the natural healing process.
Overdose
Acute overdose from topical application is unlikely. Excessive use may lead to severe skin reactions, including intense erythema, scaling, pruritus, and a painful burning sensation.
In case of accidental ingestion, seek immediate medical attention. Symptoms may include gastrointestinal irritation, nausea, and vomiting. Treatment is supportive and directed at alleviating the presenting symptoms.
Use in Pregnancy and Lactation
Use with caution during pregnancy and lactation (breastfeeding).
Pediatric Use
Use with caution in children under 12 years of age.
Special Precautions
Use with caution in children under 12 years of age.
Avoid contact with eyes and mucous membranes.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Gel for external use 10%: tube 45 g
Marketing Authorization Holder
Pierre Fabre Dermatologie (France)
Dosage Form
| Eclaran 10 | Gel for external use 10%: tube 45 g |
Dosage Form, Packaging, and Composition
| Gel for external use 10% | 1 g |
| Benzoyl peroxide | 100 mg |
45 g – polyethylene tubes (1) – cardboard packs.
Gel for external use 5%: tube 45 g
Marketing Authorization Holder
Pierre Fabre Dermatologie (France)
Dosage Form
| Eclaran 5 | Gel for external use 5%: tube 45 g |
Dosage Form, Packaging, and Composition
| Gel for external use 5% | 1 g |
| Benzoyl peroxide | 50 mg |
45 g – polyethylene tubes (1) – cardboard packs.
Phenibut-Vertex pills 250mg, 20pcs
Arbidol, capsules 100mg, 40pcs
Cortexin, 10mg, 5ml, 10pcs
Nootropil pills 800mg, 30pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Fenotropil pills 100mg, 60pcs
Mildronate capsules 500mg, 90pcs
OKI, sachets 80mg 2g, 12pcs
Picamilon pills 50mg, 60pcs
Belosalic, lotion solution for external use spray 100ml
Ingavirin capsules 90mg, 10pcs
Kagocel pills 12mg, 30pcs
Daivobet, ointment, 30g
Cerebrolysin, solution for injection 2ml ampoules 10pcs 